Course Hero Logo

After giving a test dose how long will the nurse wait

Course Hero uses AI to attempt to automatically extract content from documents to surface to you and others so you can study better, e.g., in search results, to enrich docs, and more. This preview shows page 295 - 297 out of 318 pages.

After giving a test dose, how long will the nurse wait before administering the remaining portionof the dose?a.30 minutesb.1 hourc.6 hoursd.24 hoursANS: BAlthough anaphylactic reactions usually occur within a few moments after the test dose, it isrecommended that a period of at least 1 hour elapse before the remaining portion of the initialdose is given. The other options are incorrect.DIF:COGNITIVE LEVEL: Understanding (Comprehension)REF: p. 866TOP: NURSING PROCESS: PlanningMSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
296Chapter 54: Anemia Drugs13.A patient with end-stage renal failure has been admitted to the hospital for severe anemia. She isrefusing blood transfusions. The nurse anticipates drug therapy with which drug to stimulate theproduction of red blood cells?a.Folic acidb.Cyanocobalamin (vitamin B12)c.Epoetin alfa (Epogen)d.Filgrastim (Neupogen)ANS: CEpoetin alfa is a colony-stimulating factor that is responsible for erythropoiesis, or formation ofred blood cells. The other options are incorrect.DIF:COGNITIVE LEVEL: Understanding (Comprehension)REF: p. 863TOP: NURSING PROCESS: PlanningMSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies14.A cancer patient is receiving drug therapy with epoetin alfa (Epogen). The nurse knows that themedication must be stopped if which laboratory result is noted?a.White blood cell count of 550 cells/mm3b.Hemoglobin level of 12 g/dLc.Potassium level of 4.2 mEq/Ld.Glucose level of 78 mg/dLANS: BIf epoetin is continued when hemoglobin levels are above 11 g/dL, patients may experienceserious adverse events, including heart attack, stroke, and death. Guidelines now recommend thatthe drug be stopped when the hemoglobin level reaches 10 g/dL for cancer patients. For renalpatients, the target hemoglobin level is 11 g/dL for patients on dialysis and 10 g/dL for chronicrenal patients not on dialysis.DIF:COGNITIVE LEVEL: Analyzing (Analysis)REF: p. 863TOP: NURSING PROCESS: EvaluationMSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies15.A patient has been receiving epoetin alfa (Epogen) for severe iron-deficiency anemia. Today, theprovider changed the order to darbepoetin (Aranesp). The patient questions the nurse, “What isthe difference in these drugs?” Which response by the nurse is correct?a.“There is no difference in these two drugs.”b.“Aranesp works faster than Epogen to raise your red blood cell count.”c.“Aranesp is given by mouth, so you will not need to have injections.”d.“Aranesp is a longer-acting form, so you will receive fewer injections.”ANS: DDarbepoetin (Aranesp) is longer-acting than epoetin alfa (Epogen); therefore, fewer injectionsare required. The other options are incorrect.DIF:COGNITIVE LEVEL: Applying (Application)REF: p. 863TOP: NURSING PROCESS: ImplementationMSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies

Upload your study docs or become a

Course Hero member to access this document

Upload your study docs or become a

Course Hero member to access this document

End of preview. Want to read all 318 pages?

Upload your study docs or become a

Course Hero member to access this document

Term
Fall
Professor
N/A
Tags

Newly uploaded documents

Show More

Newly uploaded documents

Show More

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture